Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03551379 · ClinicalTrials.gov registry record
A Double Balloon Endoscopic Platform for ESD
A clinical trial of Colon Polyp and Colon Adenoma, sponsored by Lumendi.
- Completed
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT03551379: Completed study of Colon Polyp and Colon Adenoma, sponsored by Lumendi.
NCT03551379 is a study of Colon Polyp and Colon Adenoma that has completed, run by Lumendi. The registered enrollment target is 15 participants, below the 158-participant average among 3 other Colon Polyp trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03551379, a study of Colon Polyp and Colon Adenoma, has completed, sponsored by Lumendi.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this observational study is to record performance of a double balloon endolumenal interventional platform during complex colon polypectomy.
Primary Outcome
Was the lesion(s) able to be removed using the DiLumen Endolumenal Interventional Platform Device \[Yes/No\]
Conditions Studied
Interventions
- DEVICE Double Balloon Endoluminal Platform
Study Locations (1)
New York
- Winthrop-NYU Langone - Mineola
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-09-22 |
| Est. Completion | 2018-09-29 |
What the finished NCT03551379 record still lists
NCT03551379 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 158-participant average among 3 other Colon Polyp trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Colon Polyp appearing as the primary indexed condition, and to 1 intervention - of which Double Balloon Endoluminal Platform is the first listed.
NCT03551379 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03551379 about?
NCT03551379 is a clinical study titled "A Double Balloon Endoscopic Platform for ESD". The purpose of this observational study is to record performance of a double balloon endolumenal interventional platform during complex colon polypectomy.
What is the current status of trial NCT03551379?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2017-09-22. Estimated completion is 2018-09-29.
What conditions does trial NCT03551379 study?
This clinical trial studies the following conditions: Colon Polyp, Colon Adenoma.
What interventions are being tested in trial NCT03551379?
The interventions under investigation include: Double Balloon Endoluminal Platform (DEVICE).
Who is sponsoring clinical trial NCT03551379?
This trial is sponsored by Lumendi, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03551379 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colon Polyp
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI